Legato Capital Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Buy
29,121
+17,999
+162% +$424K 0.06% 442
2026
Q1
$166K Sell
11,122
-8,231
-43% -$140K 0.02% 695
2025
Q4
$282K Sell
19,353
-5,823
-23% -$102K 0.02% 685
2025
Q3
$452K Sell
25,176
-22,330
-47% -$328K 0.05% 456
2025
Q2
$811K Buy
+47,506
New +$475K 0.1% 331
2025
Q1
Sell
-118,497
Closed -$1.66M 578
2024
Q4
$1.66M Buy
118,497
+40,493
+52% +$598K 0.22% 142
2024
Q3
$925K Buy
78,004
+42,600
+120% +$441K 0.11% 319
2024
Q2
$329K Buy
+35,404
New +$181K 0.04% 483

Other funds holding CORZ

Legato Capital Management's CORZ Position: Q2 2026 in Review

Legato Capital Management increased its Core Scientific (CORZ) stake by 162% in Q2 2026, buying an estimated $424K and bringing the position to 29,121 shares worth $745K. The position accounts for 0.06% of the portfolio, ranked #442.

Legato Capital Management first reported a position in CORZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.66M in Q4 2024. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Legato Capital Management held 29,121 shares of Core Scientific worth $745K as of Q2 2026.
  • Legato Capital Management bought 17,999 Core Scientific shares in Q2 2026, an estimated $424K.
  • Core Scientific made up 0.06% of Legato Capital Management's portfolio in Q2 2026, its #442 holding.
  • Legato Capital Management first reported a position in Core Scientific in Q2 2024 and has held it in 8 quarters since.
  • Legato Capital Management's Core Scientific position peaked at $1.66M in Q4 2024.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.